Association Between Oral Hypofunction, Sarcopenia and Social Frailty in Community-dwelling Older Adults
OSSF
2 other identifiers
observational
200
1 country
1
Brief Summary
Previous studies have provided a preliminary understanding of the likelihood of sarcopenia and the prevalence of sarcopenia in the elderly in the community. due to the interaction between physiological and social factors, this study aims to conduct a correlation study on muscle mass, oral function and social frailty in the elderly living in the community. This study,the Makizako social frailty screening index questionnaire and the Tilburg Frailty Indicator will be used to assess the social frailty status of the study participants. Correlation analysis with sarcopenia and oral dysfunction was also conducted to better understand the interaction between nutrition, physiology, and social connection in the elderly, which will be helpful for formulating relevant policies and promoting healthy aging in the future in extremely elderly countries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 4, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 4, 2026
CompletedFirst Submitted
Initial submission to the registry
June 10, 2026
CompletedFirst Posted
Study publicly available on registry
June 22, 2026
CompletedJune 22, 2026
June 1, 2026
7 months
June 10, 2026
June 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Based on the results of empirical research on sarcopenia in Asian countries, a diagnostic consensus was established.
* The cut-off point for abnormal grip strength is less than 28 kg for men and less than 18 kg for women * 6-meter walking speed less than 1.0 second/meter * 5-time chair stand test greater than or equal to 12 seconds * Short physical performance battery, SPPB greater than or equal to 9 points The above will be combined to determine whether sarcopenia is possible.
Baseline
Study Arms (2)
Group A
Possible sarcopenia
Group B
Non-possible sarcopenia
Interventions
Eligibility Criteria
Care centers in Taoyuan City and various districts of New Taipei City
You may qualify if:
- years old or above
- general public or institutionalized for 3 months or more
- those who accept the experimental design and are willing to sign the consent form
- dietary sources are oral intake
- those who are diagnosed as having possible sarcopenia by researchers
- years old or above
- general public or institutionalized for 3 months or more
- those who accept the experimental design and are willing to sign the consent form
- dietary sources are oral intake
- those who were determined by researchers to be non-probable sarcopenia
You may not qualify if:
- comorbidities, critical illness, pre- and post-major surgery, cancer, renal failure, liver failure, kidney disease, liver disease, malignant tumors within the past five years, inflammatory conditions (c-reactive protein \>10mg/dL)
- severely malnourished people
- long-term force-feeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chang Gung University of Science and Technology
Taoyuan, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 10, 2026
First Posted
June 22, 2026
Study Start
November 14, 2025
Primary Completion
June 4, 2026
Study Completion
June 4, 2026
Last Updated
June 22, 2026
Record last verified: 2026-06